SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Biothera Release: Imprime PGG in Combination With Monoclonal Antibody Therapy Achieves 64% Complete Response Rate in Chronic Lymphocytic Leukemia Patients